THE THERAPEUTIC BENEFIT OF ACTIVITY IN DEMENTIA CARE: EVIDENCE ACROSS COUNTRIES AND SERVICE CONTEXTS
Regier N., Gitlin L.
Laboratory Study, published in Innov Aging (2017) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Innov Aging (2017)
- Reported sample size
- —
- Source database
- Europe PMC
- PMCID
- PMC6185029
Abstract (original English)
Abstract Dementia is a public health crisis that affects a staggering 47.5 million people worldwide and will quadruple in prevalence between 2010 and 2050. There is currently no imminent cure or effective pharmacotherapy, and dementia-related behavioral symptoms carry profound costs and consequences such as caregiver burden and long-term care placement. Consequently, it is vital to identify interventions that minimize behavioral occurrences and improve or sustain quality of life. One promising non-pharmacological intervention is engagement in meaningful activity, shown to increase positive emotions and attitudes toward caregivers, improve performance in activities of daily living, quality of life and well-being, and decrease neuropsychiatric symptoms. This symposium examines the evidence for and utility of activity as a therapeutic modality in dementia care in different countries and service contexts. Aravena and Gajardo will discuss the benefits of activity implementation within a public center supporting persons with dementia and their caregivers in Chile, the Kintun Program. Novelli et al., will report the outcomes of a randomized trial of a home-based activity program in Brazil on neuropsychiatric symptoms and caregiver well-being. Mamo et al. will present the therapeutic benefits of activity within a United States center for hearing-impaired persons with dementia. Regier a
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.